Vitalhub Corp. (TSE:VHI – Get Free Report) reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as C$8.44 and last traded at C$8.39, with a volume of 82739 shares. The stock had previously closed at C$8.08.
Wall Street Analyst Weigh In
Several research analysts have commented on the stock. Cormark raised their price target on shares of Vitalhub from C$7.50 to C$8.00 in a report on Tuesday, June 11th. Canaccord Genuity Group increased their price objective on Vitalhub from C$7.50 to C$8.00 and gave the stock a “buy” rating in a research report on Monday, May 13th.
Check Out Our Latest Research Report on Vitalhub
Vitalhub Stock Performance
Vitalhub (TSE:VHI – Get Free Report) last posted its quarterly earnings data on Thursday, May 9th. The company reported C$0.04 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of C$0.07 by C($0.03). Vitalhub had a return on equity of 7.10% and a net margin of 10.34%. The company had revenue of C$15.26 million for the quarter, compared to the consensus estimate of C$14.12 million. As a group, analysts anticipate that Vitalhub Corp. will post 0.2728791 earnings per share for the current year.
About Vitalhub
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
See Also
- Five stocks we like better than Vitalhub
- How to Calculate Inflation Rate
- The Cannabis Sector: Profitability Takes Center Stage
- Market Cap Calculator: How to Calculate Market Cap
- Amazon’s Stock Plunge: Is a Prime Buying Opportunity Knocking?
- Which Wall Street Analysts are the Most Accurate?
- Buy the Dip in e.l.f. Beauty: Analysts Point to a New High
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.